AppLovin shifted from speculative tech to high-margin cash machine. Explosive growth and profits — but rising valuation demands caution.
Investment Insights
Amazon (AMZN):Tech Giant Reinventing Profitability
Ticker: AMZN | Sector: Consumer Discretionary – E-Commerce & Cloud | Market Cap (Dec. 2025): ~$2.48 Trillion
P/E Ratio (TTM): ~32x | Price/FCF (TTM): ~235x | Current Price: $232
Final Verdict: HOLD – Watch closely, potentially BUY on dip below $200
AMD Blows Past Margin Expectations in 2025: Should You Buy Before the Next AI Rally?
In 2025, AMD posts record margins, boosted by AI, but its stretched valuation calls for caution before buying at the top.
AMAT: the discreet king of global technological infrastructure
Ticker: AMAT | Sector: Semiconductors | Market Cap (Dec. 2025): ~$206 Billion | P/E Ratio: ~30x | Price/FCF: ~42x
Final Verdict: HOLD with monitoring – potentially a BUY on pullback
Abbott Laboratories (ABT): Is This Medical Giant Still Flying Under the Radar?
Abbott (ABT) is posting record margins and strong profitability in 2025. At $127, the stock remains an attractive defensive play to accumulate on pullbacks.
AbbVie (ABBV) 2026: Strong Yield, but at What Cost?
AbbVie (ABBV) appeals with its strong cash flow, generous dividends, and solid margins. But behind this attractive yield lie a high valuation and a sharp earnings decline that raise concerns.
